Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis

E. Du, Monica Diez-Silva, Gregory J. Kato, Ming Dao, Subra Suresh

Research output: Contribution to journalArticle

Abstract

We developed a microfluidics-based model to quantify cell-level processes modulating the pathophysiology of sickle cell disease (SCD). This in vitro model enabled quantitative investigations of the kinetics of cell sickling, unsickling, and cell rheology. We created short-term and long-termhypoxic conditions to simulate normal and retarded transit scenarios in microvasculature. Using blood samples from 25 SCD patients with sickle hemoglobin (HbS) levels varying from 64 to 90.1%, we investigated how cell biophysical alterations during blood flow correlated with hematological parameters, HbS level, and hydroxyurea (HU) therapy. From these measurements, we identified two severe cases of SCD that were also independently validated as severe from a genotype-based disease severity classification. These results point to the potential of this method as a diagnostic indicator of disease severity. In addition, we investigated the role of cell density in the kinetics of cell sickling. We observed an effect of HU therapy mainly in relatively dense cell populations, and that the sickled fraction increased with cell density. These results lend support to the possibility that the microfluidic platform developed here offers a unique and quantitative approach to assess the kinetic, rheological, and hematological factors involved in vasoocclusive events associated with SCD and to develop alternative diagnostic tools for disease severity to supplement other methods. Such insights may also lead to a better understanding of the pathogenic basis and mechanism of drug response in SCD.

Original languageEnglish (US)
Pages (from-to)1422-1427
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume112
Issue number5
DOIs
StatePublished - Feb 3 2015
Externally publishedYes

Fingerprint

Sickle Cell Anemia
Microfluidics
Hydroxyurea
Cell Count
Sickle Hemoglobin
Rheology
Microvessels
Genotype
Therapeutics
Pharmaceutical Preparations
Population

Keywords

  • Aes-103
  • Capillary obstruction ratio
  • Cell deformability
  • Sickle cell anemia
  • Vasoocclusion

ASJC Scopus subject areas

  • General

Cite this

Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis. / Du, E.; Diez-Silva, Monica; Kato, Gregory J.; Dao, Ming; Suresh, Subra.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, No. 5, 03.02.2015, p. 1422-1427.

Research output: Contribution to journalArticle

Du, E. ; Diez-Silva, Monica ; Kato, Gregory J. ; Dao, Ming ; Suresh, Subra. / Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis. In: Proceedings of the National Academy of Sciences of the United States of America. 2015 ; Vol. 112, No. 5. pp. 1422-1427.
@article{078ff5463baf48169192114db6cef926,
title = "Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis",
abstract = "We developed a microfluidics-based model to quantify cell-level processes modulating the pathophysiology of sickle cell disease (SCD). This in vitro model enabled quantitative investigations of the kinetics of cell sickling, unsickling, and cell rheology. We created short-term and long-termhypoxic conditions to simulate normal and retarded transit scenarios in microvasculature. Using blood samples from 25 SCD patients with sickle hemoglobin (HbS) levels varying from 64 to 90.1{\%}, we investigated how cell biophysical alterations during blood flow correlated with hematological parameters, HbS level, and hydroxyurea (HU) therapy. From these measurements, we identified two severe cases of SCD that were also independently validated as severe from a genotype-based disease severity classification. These results point to the potential of this method as a diagnostic indicator of disease severity. In addition, we investigated the role of cell density in the kinetics of cell sickling. We observed an effect of HU therapy mainly in relatively dense cell populations, and that the sickled fraction increased with cell density. These results lend support to the possibility that the microfluidic platform developed here offers a unique and quantitative approach to assess the kinetic, rheological, and hematological factors involved in vasoocclusive events associated with SCD and to develop alternative diagnostic tools for disease severity to supplement other methods. Such insights may also lead to a better understanding of the pathogenic basis and mechanism of drug response in SCD.",
keywords = "Aes-103, Capillary obstruction ratio, Cell deformability, Sickle cell anemia, Vasoocclusion",
author = "E. Du and Monica Diez-Silva and Kato, {Gregory J.} and Ming Dao and Subra Suresh",
year = "2015",
month = "2",
day = "3",
doi = "10.1073/pnas.1424111112",
language = "English (US)",
volume = "112",
pages = "1422--1427",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "5",

}

TY - JOUR

T1 - Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis

AU - Du, E.

AU - Diez-Silva, Monica

AU - Kato, Gregory J.

AU - Dao, Ming

AU - Suresh, Subra

PY - 2015/2/3

Y1 - 2015/2/3

N2 - We developed a microfluidics-based model to quantify cell-level processes modulating the pathophysiology of sickle cell disease (SCD). This in vitro model enabled quantitative investigations of the kinetics of cell sickling, unsickling, and cell rheology. We created short-term and long-termhypoxic conditions to simulate normal and retarded transit scenarios in microvasculature. Using blood samples from 25 SCD patients with sickle hemoglobin (HbS) levels varying from 64 to 90.1%, we investigated how cell biophysical alterations during blood flow correlated with hematological parameters, HbS level, and hydroxyurea (HU) therapy. From these measurements, we identified two severe cases of SCD that were also independently validated as severe from a genotype-based disease severity classification. These results point to the potential of this method as a diagnostic indicator of disease severity. In addition, we investigated the role of cell density in the kinetics of cell sickling. We observed an effect of HU therapy mainly in relatively dense cell populations, and that the sickled fraction increased with cell density. These results lend support to the possibility that the microfluidic platform developed here offers a unique and quantitative approach to assess the kinetic, rheological, and hematological factors involved in vasoocclusive events associated with SCD and to develop alternative diagnostic tools for disease severity to supplement other methods. Such insights may also lead to a better understanding of the pathogenic basis and mechanism of drug response in SCD.

AB - We developed a microfluidics-based model to quantify cell-level processes modulating the pathophysiology of sickle cell disease (SCD). This in vitro model enabled quantitative investigations of the kinetics of cell sickling, unsickling, and cell rheology. We created short-term and long-termhypoxic conditions to simulate normal and retarded transit scenarios in microvasculature. Using blood samples from 25 SCD patients with sickle hemoglobin (HbS) levels varying from 64 to 90.1%, we investigated how cell biophysical alterations during blood flow correlated with hematological parameters, HbS level, and hydroxyurea (HU) therapy. From these measurements, we identified two severe cases of SCD that were also independently validated as severe from a genotype-based disease severity classification. These results point to the potential of this method as a diagnostic indicator of disease severity. In addition, we investigated the role of cell density in the kinetics of cell sickling. We observed an effect of HU therapy mainly in relatively dense cell populations, and that the sickled fraction increased with cell density. These results lend support to the possibility that the microfluidic platform developed here offers a unique and quantitative approach to assess the kinetic, rheological, and hematological factors involved in vasoocclusive events associated with SCD and to develop alternative diagnostic tools for disease severity to supplement other methods. Such insights may also lead to a better understanding of the pathogenic basis and mechanism of drug response in SCD.

KW - Aes-103

KW - Capillary obstruction ratio

KW - Cell deformability

KW - Sickle cell anemia

KW - Vasoocclusion

UR - http://www.scopus.com/inward/record.url?scp=84922370758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922370758&partnerID=8YFLogxK

U2 - 10.1073/pnas.1424111112

DO - 10.1073/pnas.1424111112

M3 - Article

C2 - 25605910

AN - SCOPUS:84922370758

VL - 112

SP - 1422

EP - 1427

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 5

ER -